1The technology development trends in the field of artificial intelligence-assisted drug discovery based on patent analysisZHANG Ting, CHEN Juan, OUYANG Zhao-lian305-3112Study on the impact heterogeneity of government subsidies and R&D investment on pharmaceutical enterprise performanceYANG Huan, WANG Jia-luo, GAO Zi-wen, CHU Shu-zhen312-3183A brief analysis on the influence of the prior art with the same reaction site on the inventiveness assessment of synthetic method inventionWANG Lei, XU Wei319-3224Background and key elements of"Guidance for Writing Pediatric Information in Labelings of Chemical Drugs and Biological Products ( Trial)"GENG Ying, ZHANG Hao, WANG Li-qing, LIANG Yu-guang, WANG Xiao-chuan, SUN Yan-zhe, LI Qiang, WANG Xiao-ling, YANG Zhi-min323-3285Progress in research on drug metabolism in juvenile animalsLI Guang-lu, ZHANG Wen-peng, WU Chun-qi, ZHUANG Xiao-mei, ZHANG Tian-hong, WANG Quan-jun329-3366Study on proficiency testing of determination of aflatoxin B1 residues in Polygalae radixLI Yao-lei, LI Hai-liang, ZAN Ke, WANG Dan-dan, XIANG Xin-hua, JIN Hong-yu, MA Shuang-cheng337-3427An update on the combinations with β-lactamase inhibitorsZONG Hui, SUN Yu-fang, CHEN Si-min, AN Mao-mao, SHEN Hui343-3518Research progress on in vitro models to study drug delivery in the posterior segment of the eyeLI Ya-min, CHEN Xue-feng, LIANG Li-na352-3569Research on randomized,open label,double-period,double-cross bioequivalence trial of lenvatinib mesylate capsulesSONG Hao-jing, QIU Bo, SUN Xue, GUO Ni-ni, HU Yi-ting, BAI Wan-jun, GUO Cai-hui, DONG Zhan-jun357-36110In silico study of the anti-inflammatory activity of Portulaca oleracea L. ingredientsLV Jun-ping, ZHOU Lu, SHI Dong-xu, A Ru-na, PANG Zong-ran, LU Bi-nan369-37511Stability and influencing factors of amoxicillin clavulanate potassium tabletsCHONG Xiao-meng, TIAN Ye, YAO Shang-chen, YIN Li-hui, LIU Ying, XU Ming-zhe376-38312Study on the pharmacokinetic properties of the cosolvent ethyl lactateYOU Jing, CHEN Xiao-yun, CAO Jing-jie, WANG Yi-ling, ZHANG Li, OUYANG Qi, LAN Bo, HUANG Yu-lan, CHEN Jun, LU Wu-dang, MEI Qi-bing384-39013Rapid health technology evaluation of anti-angiogenic drug aflibercept in the treatment of metastatic colorectal cancerWANG Jun-ping, WANG Guo-yu, ZHANG Mei, WU Zheng-yu, ZHOU Peng, XIA Li391-39614Comprehensive clinical evaluation of three kinds of triple viable agents containing bifidobacteria in the treatment of diarrheaSHI Gui-ze, LIN Teng-fei, ZHANG Tian-tian, JIANG Jie397-408 